Acute and transient podocyte loss and proteinuria in preeclampsia

Nephron - Clinical Practice

Volumn 112, Issue 2, 2009, Pages

  Aita, Kumi ^a   Etoh, Mio ^a   Hamada, Hiromi ^a   Yokoyama, Chie ^a   Takahashi, Ayuko ^a   Suzuki, Taisei ^a   Hara, Masanori ^b   Nagata, Michio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Yoshida Hospital   (Japan)

Author keywords

Glomerular endothelial cells; Podocyturia; Preeclampsia; Proteinuria

Indexed keywords

PODOCALYXIN;

ARTICLE; BLOOD PRESSURE; CELL COUNT; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATION PERIOD; HUMAN; IMMUNOFLUORESCENCE; PODOCYTE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; URINALYSIS; URINARY EXCRETION; URINE SEDIMENT;

BIOLOGICAL MARKERS; FEMALE; HUMANS; PODOCYTES; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA;

EID: 65449140329     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000213083     Document Type: Article

References (18)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
2. Sato K: A proposal for a new definition and classification of 'Pregnancy induced Hypertension (PIH)' (in Japanese). Hypertens Preg nancy 2003;11:15-44.
3. Krane NK, Hamrahian M: Pregnancy: kidney diseases and hypertension. Am J Kidney Dis 2007;49:336-345.
4. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sell-ke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi A: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-658.
5. Park CW, Park LS, Shim SS, Jun JK, Yoon BH, Romero R : A n ele vated mater na l plasma but not amniotic f luid, soluble fms-like tyro-sine kinase-1 (sFLT-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia. Am J Obstet Gynecol 2005; 193(suppl):984-989.
6. Eremina V, Baelde HJ, Quaggin SE: Role of the VEGF-a signaling pathway in the glo-merulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 2007;106:32-37.
7. Vogelmann SU, Nelson WJ, Myes BD, Lem-ley K: Urinary excretion of viable podocytes in health and renal disease. Am J Renal Physiol 2003;285:F40-F48.
8. Hara M, Yamamoto T, Yanagihara T, Takada T, Itoh M, Adachi Y, Yoshi zumi A, Kawasak i K, Kihara I: Urinary excretion of podocaly-xin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron 1995; 69:397-403.
9. Hara M, Yanagihara T, Kihara I: Urinary podocytes in primary focal segmental glo-merulosclerosis. Nephron 2001;89:342-347.
10. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H: Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 2000;15:1379-1383.
11. Garovic VD, Wagner SJ, Turner ST, Rosen-thal DW, Watson WJ, Brost BC, Rose CH, Gavrilova L, Craigo P, Bailey KD, Achen-bach J, Schi ffer M, Gra nde JP: Urinary podo-cyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 2007;320:e1-e7.
12. Shankland SJ: The podocyte's response to injury: role in proteinuria and glomeruloscle-rosis. Kidney Int 2006;69:2131-2147.
13. Nagata M, Kriz W: Glomerular damage after uninephrectomy in young rats. II Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 1992;42:148-160.
14. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, Kershaw D, Wiggins R: Podocyte depletion and glomerulosclero-sis have a direct relationship in the PAN-treated rat. Kidney Int 2001;60:957-968.
15. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Meyers BD: Podocyt-openia and disease activity in IgA nephropa-thy. Kidney Int 2002;61:1475-1485.
16. Pagtalunan EP, Miller PL, Jumping-Eagle S, Nelson RG, Meyers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997;99:342-348.
17. Garovic VD, Hayman SR: Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 2007;3:613-622 .
18. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM: Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008; 21;359:800-809.